tiprankstipranks
Molecular Partners Expands Radio-DARPin Pipeline and Advances Clinical Trials at Healthcare Conference
PremiumCompany AnnouncementsMolecular Partners Expands Radio-DARPin Pipeline and Advances Clinical Trials at Healthcare Conference
2M ago
Molecular Partners Advances Radio-DARPin Programs with Strong Funding
Premium
Company Announcements
Molecular Partners Advances Radio-DARPin Programs with Strong Funding
5M ago
Molecular Partners backs FY24 total expenses  view of of CHF 65M-CHF 70M
Premium
The Fly
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M
5M ago
Molecular Partners AG (ADR) trading resumes
PremiumThe FlyMolecular Partners AG (ADR) trading resumes
6M ago
Molecular Partners AG (ADR) trading halted, volatility trading pause
Premium
The Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
6M ago
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
Premium
The Fly
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
7M ago
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe FlyMolecular Partners AG (ADR) trading halted, volatility trading pause
9M ago
Molecular Partners’ New Therapy Shows AML Treatment Promise
Premium
Company Announcements
Molecular Partners’ New Therapy Shows AML Treatment Promise
9M ago
Molecular Partners announces preclinical data from MP0621 trial
Premium
The Fly
Molecular Partners announces preclinical data from MP0621 trial
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100